Valuation : BioElectronics Corporation

Market Cap 12.35M 10.6M 9.93M 9.09M 17.12M 1.18B 17.17M 118M 45.95M 595M 46.38M 45.38M 1.97B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.06M 20.65M 18.91M 35.62M 2.45B 35.72M 245M 95.59M 1.24B 96.47M 94.39M 4.09B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+60.00%
Current month+33.33%
1 month+14.29%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 14/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 14/11/2019
Chairman 85 14/06/2020
Director/Board Member - 02/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+60.00%+300.00%-20.00% 6.67M
-0.70%+0.50%+29.21%+16.45% 233B
-0.26%-0.11%+5.21%-15.60% 152B
+1.16%-1.98%-22.09%+23.36% 130B
+0.85%-5.47%-55.92%-8.06% 67.64B
+0.31%+0.13%+11.19%+18.09% 51.85B
+0.57%-1.72%-16.59%-13.64% 50.91B
-1.59%+0.89%+32.86%+31.76% 44.46B
-0.44%+4.09%+42.98%+54.10% 41.39B
+1.53%+3.20%-16.39%+46.45% 34.01B
Average +0.14%-0.40%+31.05%+13.29% 80.48B
Weighted average by Cap. +0.05%-0.56%+4.19%+11.72%

Financials

2020 2021
Net sales 830K 712K 667K 610K 1.15M 79.23M 1.15M 7.89M 3.09M 39.93M 3.11M 3.05M 132M 1.61M 1.38M 1.29M 1.18M 2.23M 154M 2.24M 15.32M 5.99M 77.47M 6.04M 5.91M 256M
Net income -1.16M -996K -932K -853K -1.61M -111M -1.61M -11.04M -4.31M -55.82M -4.35M -4.26M -185M -290K -249K -233K -213K -402K -27.68M -403K -2.76M -1.08M -13.95M -1.09M -1.06M -46.17M
Net Debt 13.07M 11.22M 10.5M 9.62M 18.12M 1.25B 18.17M 124M 48.61M 629M 49.06M 48M 2.08B 13.34M 11.45M 10.72M 9.82M 18.5M 1.27B 18.55M 127M 49.63M 642M 50.09M 49.01M 2.13B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
27/08/26 US$0.000270 -10.00% 1,672,000
26/08/26 US$0.000300 -.--% 158,300
25/08/26 US$0.000300 -.--% 12,484,589
24/08/26 US$0.000300 -.--% 1,793,250
21/08/26 US$0.000300 +20.00% 444,250
  1. Stock Market
  2. Stocks
  3. BIEL Stock